Biotech Cluster Munich-Martinsried
Your contact
Prof. Dr. Ralf Huss
Managing Director
Munich with Martinsried is a leading biotechnology location
The European metropolitan area of Munich is the leading biotechnology location in Germany and enjoys a leading position in Europe.
over 450 life sciences companies
2 elite-universities: Ludwig-Maximilians-Universität and Technische Universität München
Helmholtz Munich – German Research Center for Environmental Health
3 biological/medical Max Planck Institutes: for Biochemistry, for Biological Intelligence and for Psychiatry
2 university hospitals: Klinikum rechts der Isar and Klinikum der Universität München as well as 60 other hospitals
2 Innovation- and start-up centers specializing in biotechnology
Focus on drug development
The location is particularly benefiting from close networking between academic research and the biotech industry. The majority of medium-sized biotechnology companies are spin-offs of scientific institutions. The region is dynamic: almost 100 new start-ups have been established since 2015. The region is concentrated: companies emphasize "red biotechnology", that is: the development of therapeutics and diagnostics. Its special powers are personalized medicine and immunotherapy.
Incubators
The Biotechnology Innovation and Start-up Centers (IZB) offer state-of-the-art laboratories and office space for young biotechnology companies. The start-ups benefit from the contacts and the creative environment in the incubator and from the proximity to academic research at the universities in Weihenstephan and Martinsried.
IZB Planegg-Martinsried specializes in pharmaceuticals and services
IZB Freising-Weihenstephan specializes in phyto-pharmaceuticals, agronomical and food
A total of more than 25,000 sqm is available.
-
Bio<sup>M</sup>, bioRN and ESMT Berlin join forces to create a Unified Hub for healthcare innovation in Germany21.07.2026BioM, bioRN and ESMT Berlin join forces to create a Unified Hub for healthcare innovation in GermanyBioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two… -
TigerShark Science celebrates a double success: the Bavarian Start-up Award and victory in the Northern Bavaria Business Plan Competition.21.07.2026TigerShark Science celebrates a double success: the Bavarian Start-up Award and victory in the Northern Bavaria Business Plan Competition.A major success for the Würzburg-based biotech start-up TigerShark Science: the company has been awarded the 2026 Bavarian Start-up Prize in the ‘Start-up’ category. The team also secured… -
Munich start-up and m<sup>4</sup> Award winner BugSense receives EXIST funding for rapid UTI diagnostics17.07.2026Munich start-up and m4 Award winner BugSense receives EXIST funding for rapid UTI diagnosticsMunich-based start-up BugSense Diagnostics has secured EUR 1.23 million through the EXIST Research Transfer funding programme of the German Federal Ministry for Economic Affairs and Energy… -
m<sup>4</sup> award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteria06.07.2026m4 award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteriaMunich-based m4 Award winner smartbax has successfully expanded its pre-Series A funding round to a total of 6.3 million euros. With the additional capital, the biotech company plans to… -
m<sup>4</sup> Award winner Mallia secures EUR 3 million financing to accelerate commercial expansion of the 8T3 Essentials Line01.07.2026m4 Award winner Mallia secures EUR 3 million financing to accelerate commercial expansion of the 8T3 Essentials LineMallia Innovations GmbH, strategically driving the development and commercialization of biopharmaceutical therapies targeting hair loss and wound healing as well as cosmetic applications for… -
Roche's Dr. Anna Bauer-Mehren joins AI4Biotech Session – Navigating the AI Transition in Biotech and Life Sciences25.06.2026Roche's Dr. Anna Bauer-Mehren joins AI4Biotech Session – Navigating the AI Transition in Biotech and Life SciencesThe expert line-up for BioM's "AI4Biotech Session – Biotech AI Compass: Lead Your Organization Through the AI Transition" is complete: Dr. Anna Bauer-Mehren, a trained bioinformatician who… -
Merck Future Insight Prize 2026 Awarded to Vasilis Ntziachristos, Founder of Spear24.06.2026Merck Future Insight Prize 2026 Awarded to Vasilis Ntziachristos, Founder of SpearProf. Dr. Vasilis Ntziachristos, co-founder of Spear, a spin-off of Helmholtz Munich and the Technical University of Munich, has been awarded the Merck Future Insight Prize 2026. The prize… -
CollimateHealth secures EUR 6 million oversubscribed seed financing for clinically scalable microbeam radiation therapy for cancer patients12.06.2026CollimateHealth secures EUR 6 million oversubscribed seed financing for clinically scalable microbeam radiation therapy for cancer patientsMunich-based CollimateHealth has closed an oversubscribed EUR 6 million seed financing round to advance its clinically scalable microbeam radiation therapy, a radically new biological… -
BayOConnect 2026: Austria and Galicia bring international impulses to Munich10.06.2026BayOConnect 2026: Austria and Galicia bring international impulses to MunichWith Austria and Galicia, BayOConnect 2026 puts two partner regions center stage that stand for international collaboration, scientific excellence and new opportunities in the life sciences.… -
Secure the Early Bird rate and benefit from the Bio<sup>M</sup> discount!10.06.2026Secure the Early Bird rate and benefit from the BioM discount!BIO-Europe BIO-Europe 2026 will take place from November 9 to 11, 2026 in Cologne, Germany, followed by Digital Partnering on November 17 and 18. Secure your ticket at the Early Bird rate by…